Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Establishing a Th17 based mouse model for preclinical assessment of the toxicity of candidate microbicides.

Li LZ, Yang Y, Yuan SH, Wan YM, Qiu C, Feng YL, Xu JQ, Zhang XY.

Chin Med J (Engl). 2010 Dec;123(23):3381-8.

PMID:
22166518
2.

Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.

Aranha CC, Gupta SM, Reddy KV.

Cytokine. 2008 Jul;43(1):63-70. doi: 10.1016/j.cyto.2008.04.005. Epub 2008 May 29.

PMID:
18513989
3.

Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.

Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF.

Biol Reprod. 2004 Sep;71(3):761-9. Epub 2004 May 5.

PMID:
15128598
5.

Preclinical assessment of the proinflammatory potential of microbicide candidates.

Doncel GF, Chandra N, Fichorova RN.

J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S174-80.

PMID:
16419269
6.

A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.

Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.

J Infect Dis. 2007 May 1;195(9):1332-9. Epub 2007 Mar 19.

PMID:
17397004
7.

Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.

Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC.

BMC Pharmacol Toxicol. 2012 Oct 1;13:9. doi: 10.1186/2050-6511-13-9.

8.
9.

Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.

Drescher KM, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2302-12.

PMID:
8843914
11.

Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.

Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B.

Antimicrob Agents Chemother. 2004 May;48(5):1837-47.

12.

Biomarkers of leukocyte traffic and activation in the vaginal mucosa.

Trifonova RT, Bajpai M, Pasicznyk JM, Chandra N, Doncel GF, Fichorova RN.

Biomarkers. 2007 Nov-Dec;12(6):608-22.

PMID:
17852080
13.

Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.

Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1498-508. doi: 10.1089/AID.2012.0084. Epub 2012 Sep 11.

PMID:
22867271
14.

Guiding the vaginal microbicide trials with biomarkers of inflammation.

Fichorova RN.

J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S184-93. Review.

15.

Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.

Trifonova RT, Pasicznyk JM, Fichorova RN.

Antimicrob Agents Chemother. 2006 Dec;50(12):4005-10. Epub 2006 Oct 9.

16.

Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models.

Young SH, Antonini JM, Roberts JR, Erdely AD, Zeidler-Erdely PC.

J Immunol Methods. 2008 Feb 29;331(1-2):59-68. Epub 2007 Dec 17.

PMID:
18089291
17.

Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model.

Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM.

Biol Reprod. 2010 Mar;82(3):617-27. doi: 10.1095/biolreprod.109.080408. Epub 2009 Dec 9.

PMID:
20007410
19.

Clinical development of microbicides for the prevention of HIV infection.

D'Cruz OJ, Uckun FM.

Curr Pharm Des. 2004;10(3):315-36. Review.

PMID:
14754390
20.

A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation.

Fichorova RN, Mendonca K, Yamamoto HS, Murray R, Chandra N, Doncel GF.

Toxicol Appl Pharmacol. 2015 Jun 15;285(3):198-206. doi: 10.1016/j.taap.2015.02.017. Epub 2015 Mar 25.

PMID:
25818602

Supplemental Content

Support Center